Suchergebnisse - "Q20Q21Q62J"

PubPharm (59.709)

1

Cisplatin-induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP-1/CCL2 and LTB4/LTB4R pathways

enthalten in: Cell proliferation | 2024

von Nie, J. | Ai, J. | Hong, W. | +8

2

PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer

enthalten in: Environmental toxicology | 2024

von Li, P. | Wang, W. | Zhu, B. | +5

3

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

4

Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC) : Study protocol

enthalten in: Thoracic cancer | 2024

von Deng, L. | Shayan, G. | Jiang, W. | +2

5

Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways

enthalten in: Journal of ethnopharmacology | 2024

von Guo, J. | Le, Y. | Yuan, A. | +7

6

Delivery of miR-29a improves the permeability of cisplatin by downregulating collagen I expression

enthalten in: Biochemical and biophysical research communications | 2024

von Qin, Z. | Ma, J. | Chu, X. | +3

7

A Pt(II) complex bearing N-heterocycle ring induced ferroptotic cell death in ovarian cancer

enthalten in: Journal of inorganic biochemistry | 2024

von Shen, X. | Peng, Y. | Zhou, H. | +3

8

Comment on "Dexamethasone-sparing on days 2-4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin : a randomized phase III trial (SPARED Trial)"

enthalten in: British journal of cancer | 2024

von Celio, L. | Antonuzzo, A. | Aapro, M.

9

TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling

enthalten in: Biochemical pharmacology | 2024

von Ding, X. | Jin, Y. | Shi, X. | +6

10

Combined genetic polymorphisms of the GSTT1 and NRF2 genes increase susceptibility to cisplatin-induced ototoxicity : A preliminary study

enthalten in: Hearing research | 2024

von Fujikawa, T. | Ito, T. | Okada, R. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[5971]